HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Power & Pride Don’t-B-Bald Hair Care Cited As Unapproved New Drug By FDA

This article was originally published in The Rose Sheet

Executive Summary

Anti-baldness claims for Power & Pride's Don't-B-Bald Hair Care Treatment and Don't-B-Bald Scalp Stimulate render the products unapproved new drugs, FDA says in a recently released warning letter to the Houston, Texas hair care marketer
Advertisement

Related Content

Farouk Systems Power Plus Hair Loss Prevention Claims Revised
Farouk Systems Power Plus Hair Loss Prevention Claims Revised
Advertisement
UsernamePublicRestriction

Register

RS011130

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel